Aquisição de Nivolumab 10 mg/ml Conc Sol Perf 10 ml IV e Nivolumab 10 mg/ml Sol Inj Fr 4 ML IV

ID 9136398 · Portal BASE
Price
Base Price
€9,576 .00
Effective Price
€9,576 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Loures
Bidder Count
—
Winner
BRISTOL - MYERS SQUIBB FARMACÊUTICA PORTUGUESA, S.A.
NIF 500048193
Company
Dates
Publication
22 Mar 2022
Celebration
14 Feb 2022
Contracting Entity
Unidade Local de Saúde de Loures-Odivelas, EPE
NIF 516726862
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 90 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
1245
Supplier
18
Number of Awards
3
Rule
A1 repeat direct award: 3 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
22 Mar 2022
Signing Date
14 Feb 2022
Days Late
36
Rule
A2/A3 late publication: 36 days after signing (threshold: 10)
Detected 2026-03-06